-transparent.png){kind=logo}
A LHRH-like substance is detectable in the urine. It is extractable by glass powder, which suggests that it is a peptide, and it can be concentrated by anti-LHRH affinity chromatography, strongly suggesting that it is not a contaminant in the RIA. It is composed of very little intact LHRH, and the great majority appears as multiple smaller fractions, although the possibility of "urinary LHRH" being a slightly larger peptide containing a sequence similar or identical to that of LHRH has not been entirely eliminated. Urinary measurements show no correlation with the clinical state, and the widely differing values obtained using different antisera in the present study emphasize the need for in-depth antiserum binding studies prior to clinical use in the LHRH radioimmunoassay.
P C Sizonenko, and
K C Copeland, and
L Paunier, and
M L Aubert
July 1976,
Scandinavian journal of clinical and laboratory investigation,
P C Sizonenko, and
K C Copeland, and
L Paunier, and
M L Aubert
February 1991,
International journal of andrology,
P C Sizonenko, and
K C Copeland, and
L Paunier, and
M L Aubert
September 1985,
Clinica chimica acta; international journal of clinical chemistry,
P C Sizonenko, and
K C Copeland, and
L Paunier, and
M L Aubert
March 1982,
Rinsho byori. The Japanese journal of clinical pathology,
P C Sizonenko, and
K C Copeland, and
L Paunier, and
M L Aubert
June 1977,
Steroids,
P C Sizonenko, and
K C Copeland, and
L Paunier, and
M L Aubert
January 1975,
Ginekologia polska,
P C Sizonenko, and
K C Copeland, and
L Paunier, and
M L Aubert
June 1980,
Prostaglandins and medicine,
P C Sizonenko, and
K C Copeland, and
L Paunier, and
M L Aubert
March 1984,
Journal of immunological methods,
P C Sizonenko, and
K C Copeland, and
L Paunier, and
M L Aubert
September 1973,
Prostaglandins,
P C Sizonenko, and
K C Copeland, and
L Paunier, and
M L Aubert
September 1965,
Nihon Naibunpi Gakkai zasshi,
